Save the date! On July 28th, Gateway Analytical is hosting “Flow Imaging Microscopy: When Subvisible Particle Counts Aren’t Enough.“
We’ll map out an investigation decision tree and a feasibility-first approach so you can quickly evaluate if Flow Imaging Microscopy (FIM) fits your project constraints, saving you time and ensuring compliance on your journey to market..
Register Here:
This expert-led panel will explore the benefits of Flow Imaging Microscopy (FIM) across injectable modalities such as high-concentration protein biologics, peptides, long-chain molecules, ADCs/conjugates, and products involving fill-finish or container-closure interactions.
What You’ll Learn:
Recognize common investigation triggers where subvisible particles count alone can delay decisions.
Apply a practical decision framework for image-based evaluation, and when to escalate to chemical and elemental identification when identity and attribution are required.
Identify best-fit product modalities and risk scenarios where FIM typically adds the most value, including high-concentration proteins, peptides, long-chain molecules, ADCs/conjugates, and fill–finish/container-closure interaction risks.
Interpret core FIM deliverables and outline a feasibility-first plan to assess method suitability for challenging matrices and define the next best testing steps.
Join an insightful presentation on issues that can arise at critical stages of the product lifecycle.
Register today and take a proactive step toward safer, more compliant CGT practices. For more information, contact Gateway Analytical at (724) 443-1900 or in**@***************al.com.
